E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 5/17/2022 in the Prospect News Structured Products Daily.

New Issue: Barclays prices $1.13 million callable contingent coupon notes on index, ETFs

Chicago, May 17 – Barclays Bank plc priced $1.13 million of callable contingent coupon notes due Oct. 26, 2023 linked to the least performing of the S&P 500 index, the SPDR S&P Biotech ETF and the SPDR S&P Regional Banking ETF, according to a 424B2 filing with the Securities and Exchange Commission.

The notes pay a contingent quarterly coupon at an annualized rate of 12% if each underlier closes at or above its coupon barrier level, 70% of its initial level, on the related observation date.

The notes will be callable in whole at par plus any coupon due on any quarterly call date.

If the notes are not redeemed early and the worst performer finishes at or above its 70% final barrier level, the payout at maturity will be par. Otherwise, investors will be fully exposed to the decline of the worst performer from its initial level.

Barclays is the agent.

Issuer:Barclays Bank plc
Issue:Callable contingent coupon notes
Underlying assets:S&P 500 index, the SPDR S&P Biotech ETF and the SPDR S&P Regional Banking ETF
Amount:$1,131,000
Maturity:Oct. 26, 2023
Contingent coupon:12% per year, payable quarterly if each underlier closes at or above coupon barrier on the observation date for that period
Price:Par
Payout at maturity:If each underlier finishes at or above final barrier, par; otherwise, loss of 1% for every 1% decline of the worst performer from its initial level
Call option:In whole at par plus any coupon due on any quarterly call date
Initial levels:4,544.9 for S&P, $124.18 for Biotech, $72.78 for Banking
Coupon barriers:3,181.43 for S&P, $86.93 for Biotech, $50.95 for Banking; 70% of initial levels
Final barrier levels:3,181.43 for S&P, $86.93 for Biotech, $50.95 for Banking; 70% of initial levels
Pricing date:Oct. 22, 2021
Settlement date:Oct. 27, 2021
Agent:Barclays
Fees:1.5%
Cusip:06748WP49

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.